Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM) José-Vicente Torregrosa; Jordi Bover; Mariano Rodríguez Portillo; Emilio González Parra; María Dolores Arenas; Francisco Caravaca; María-Luisa González Casaus; Alejandro Martín-Malo; Juan Francisco Navarro-González; Víctor Lorenzo; Pablo Molina; Minerva Rodríguez; Jorge Cannata Andia;

Multicenter validation of the Kidney Failure Risk Equation (KFRE) formula in Spanish patients with advanced chronic kidney disease Beatriz Escamilla-Cabrera; Marco Montomoli; Maria Kislikova; Verónica de la Espada; Alazne Olarte-García; Ana María García-Prieto; Sara Piqueras-Sánchez; Álvaro Álvarez López; Lucía Rodríguez-Gayo; Javier Centellas-Pérez; Hilda Villafuerte; Pedro Barrera Baena;